C. Lisanti
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 5
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 2
-
- Cancer Genomics and Diagnostics 3
- Breast Cancer Treatment Studies 3
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Anthony Howell (1 shared paper)Rebecca Lamb (1 shared paper)Ubaldo Martinez‐Outschoorn (1 shared paper)Federica Sotgia (1 shared paper)Herbert B. Tanowitz (1 shared paper)Béla Ózsvári (1 shared paper)Michael P. Lisanti (1 shared paper)Fabio Puglisi (22 shared papers)
- Journals
- Cancers (5 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (3 papers)Expert Opinion on Biological Therapy (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- ItalyUnited StatesArgentina
In The Last Decade
C. Lisanti
22 papers receiving 689 citations
C. Lisanti's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 167
- Oncology 269
- Otorhinolaryngology 23
- Molecular Biology 305
- Pulmonary and Respiratory Medicine 124
Countries citing papers authored by C. Lisanti
This map shows the geographic impact of C. Lisanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lisanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lisanti more than expected).
Fields of papers citing papers by C. Lisanti
This network shows the impact of papers produced by C. Lisanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lisanti. The network helps show where C. Lisanti may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Lisanti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease Hit paper breakdown → | 2015 | 389 |
| 2 | 2019 | 91 | |
| 3 | 2022 | 78 | |
| 4 | 2019 | 44 | |
| 5 | 2020 | 26 | |
| 6 | 2018 | 17 | |
| 7 | 2022 | 10 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2018 | 6 | |
| 12 | 2018 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2020 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2019 | 1 |
About C. Lisanti
C. Lisanti is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 26 papers that have together received 705 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Genomics and Diagnostics (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer, Lipids, and Metabolism (2 papers), HER2/EGFR in Cancer Research (2 papers) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Cancer Research (167 citations), Oncology (269 citations), Otorhinolaryngology (23 citations), Molecular Biology (305 citations) and Pulmonary and Respiratory Medicine (124 citations). C. Lisanti has collaborated with scholars based in Italy, United States and Argentina. Frequent co-authors include Anthony Howell, Rebecca Lamb, Ubaldo Martinez‐Outschoorn, Federica Sotgia, Herbert B. Tanowitz, Béla Ózsvári, Michael P. Lisanti, Fabio Puglisi, Paola Di Nardo and Debora Basile. Their work appears in journals such as Cancers, Journal of Clinical Oncology, Annals of Oncology, Expert Opinion on Biological Therapy and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.